Cervical Adenocarcinoma

About
Mappings

OncoTree: Cervical Adenocarcinoma (oncotree:CEAD)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) PD-L1 (CPS) >= 1 Cervical Adenocarcinoma Carboplatin, Paclitaxel, Pembrolizumab
Sensitivity (+) PD-L1 (CPS) >= 1 Cervical Adenocarcinoma Bevacizumab, Carboplatin, Paclitaxel, Pembrolizumab
Sensitivity (+) PD-L1 (CPS) >= 1 Cervical Adenocarcinoma Cisplatin, Paclitaxel, Pembrolizumab
Sensitivity (+) PD-L1 (CPS) >= 1 Cervical Adenocarcinoma Bevacizumab, Cisplatin, Paclitaxel, Pembrolizumab
Sensitivity (+) PD-L1 (CPS) >= 1 Cervical Adenocarcinoma Carboplatin, Paclitaxel, Pembrolizumab
Sensitivity (+) PD-L1 (CPS) >= 1 Cervical Adenocarcinoma Bevacizumab, Carboplatin, Paclitaxel, Pembrolizumab
Sensitivity (+) PD-L1 (CPS) >= 1 Cervical Adenocarcinoma Pembrolizumab
Sensitivity (+) PD-L1 (CPS) >= 1 Cervical Adenocarcinoma Pembrolizumab
Sensitivity (+) PD-L1 (CPS) >= 1 Cervical Adenocarcinoma Pembrolizumab
Sensitivity (+) PD-L1 (CPS) >= 1 Cervical Adenocarcinoma Bevacizumab, Carboplatin, Paclitaxel, Pembrolizumab
Sensitivity (+) PD-L1 (CPS) >= 1 Cervical Adenocarcinoma Carboplatin, Paclitaxel, Pembrolizumab